跳至主要内容
临床试验/NCT06093009
NCT06093009已完成不适用

National Cheng Kung University Hospital

National Cheng-Kung University Hospital1 个研究点 分布在 1 个国家目标入组 208 人开始时间: 2002年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
208
试验地点
1
主要终点
Overall survival

研究概览

简要总结

To assess the impact of preoperative sarcopenia and postoperative skeletal muscle wasting on the outcomes of patients with resectable pancreatic cancer who underwent pancreatectomy.

详细描述

Previous studies have revealed that sarcopenia, defined as generalized loss of skeletal muscle mass, is a poor prognostic factor following surgery. However, research focusing on postoperative muscle wasting and its influence on the prognosis of resectable pancreatic cancer (PC) is limited. Investigators retrospectively reviewed 208 patients who underwent pancreatectomy for PC at the National Cheng Kung University Hospital (NCKUH) between June 2002 and April 2020. Clinical information regarding patient characteristics, pathological parameters, and biochemical features was collected from all patients using electronic medical records (EMRs) under an IRB-approved protocol (B-ER-110-420) at NCKUH. Preoperative psoas major area and the degree of muscle reduction at 3 months postoperatively were calculated using computed tomography to define sarcopenia and drastic muscle wasting. Patients were assigned to two groups based on sarcopenia or drastic muscle wasting, and compared for postoperative morbidity, disease free survival (DFS), and overall survival (OS).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
20 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Clinical diagnosis of pancreatic cancer
  • Must be able to undergo pancreatectomy
  • Must be able to undergo pre- and post-operative abdominal computed tomography scan

排除标准

  • Unresectable pancreatic cancer

结局指标

主要结局

Overall survival

时间窗: 10 years

Overall survival was measured as the period between the date of resection and the date of the last follow-up or death.

Disease-free survival

时间窗: 10 years

Disease-free survival was defined as the duration from resection to cancer relapse (local, peritoneal recurrence, or distal metastasis).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验